Biopharmaceutical company Biocon is planning to submit a request for approval of generic copies of the blockbuster ...

The global Biosimilars Market , valued at US$32.75 billion in 2024 stood at US$35.04 billion in 2025 and is projected to ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years, a top executive told Reuters ...

As per the Global Entrepreneurship Monitor, presently, there are more than 658 million active female founders and business ...

State Bank of India (SBI), the largest lender in the country, has launched a share sale to institutional investors to raise ...

Top largecap stocks that mutual funds bought in June included Asian Paints, Trent, Bajaj Finserv, Infosys, and Bharti Airtel, ...

The global drug discovery services market is projected to grow at a CAGR of 15% from 2025 to 2030. This growth is driven by the increasing demand for outsourced drug discovery activities, advancements ...

The global healthcare landscape is in a constant state of evolution, driven by technological breakthroughs, demographic ...

HDFC Asset Management Company reported a 24% on-year jump in net profit to Rs 748 crore for the first quarter of the financial year 2026.

The Board of Directors of Oriental Hotels Limited, at its meeting held today have approved the financial results of the ...

Forbes’ 2025 list ranks Nykaa’s Falguni Nayar and Biocon’s Kiran Mazumdar-Shaw among the 50 wealthiest self-made women in the ...